Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients

Archives of Ophthalmology

Volumn 126, Issue 8, 2008, Pages 1076-1081

  Simó, Rafael ^a   Higuera, Mónica ^a   García Ramírez, Marta ^a   Canals, Francesc ^a   García Arumí, José ^a   Hernández, Cristina ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BETA2 GLYCOPROTEIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; HUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA HOLE; VITREOUS BODY; WESTERN BLOTTING;

AGED; APOLIPOPROTEIN A-I; BETA 2-GLYCOPROTEIN I; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; PROTEOMICS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITRECTOMY; VITREOUS BODY;

EID: 49449108549     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.8.1076     Document Type: Article

References (40)

1. Moss SE, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998-1003.
2. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev. 2006;2(1):71-98.
3. García-Ramírez M, Canals F, Hernández C, et al. Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia. 2007;50(6):1294-1303.
4. Simó R, Lecube A, Segura RM, Garcia-Arumi J, Hernandez C. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2002;134(3):376-382.
5. Harboe M. A method for determination of hemoglobin in plasma by nearultraviolet spectrophotometry. Scand J Clin Lab Invest. 1959;11(1):66-70.
6. Fairbanks VF, Ziesmer SC, O'Brien PC. Methods for measuring plasma hemoglobin in micromolar concentration. Clin Chem. 1992;38(1):132-140.
7. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem. 1996;68(5):850-858.
8. Alban A, David SO, Bjorkesten L, et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics. 2003;3(1):36-44.
9. Pauleikhoff D, Harper CA, Mashall J, Bird AC. Aging changes in Bruch's membrane: a histochemical and morphological study. Ophthalmology. 1990;97 (2):171-178.
10. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol. 1994;112(3):402-406.
11. Curcio CA, Millican CL, Bailey T, Kruth H. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42(1):265-274.
12. Ishida BY, Bailey KR, Duncan KG, et al. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J Lipid Res. 2004;45(2):263-271.
13. Li CM, Chung BH, Presley JB, et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci. 2005;46(7):2576-2586.
14. Li CM, Clark ME, Chimento MF, Curcio CA. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci. 2006;47(7):3119-3128.
15. Koch S, Donarski N, Goetze K, et al. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res. 2001;42(7):1143-1151.
16. Elshourbagy NA, Boguski MS, Liao WS, Jefferson LS, Gordon JI, Taylor JM. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A. 1985;82(23):8242-8246.
17. Yamane K, Minamoto A, Yamashita H, et al. Proteome analysis of human vitreous proteins. Mol Cell Proteomics. 2003;2(11):1177-1187.
18. West KA, Yan L, Shadrach K, et al. Protein database, human retinal pigment epithelium. Mol Cell Proteomics. 2003;2(1):37-49.
19. Mooradian AD, Haas MJ, Wong NCW. Transcriptional control of apolipoprotein A-I gene expression in diabetes. Diabetes. 2004;53(3):513-520.
20. Kawai S, Nakajima T, Hokari S, Komoda T, Kawai K. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Ann Clin Biochem. 2002;39(pt 1):56-61.
21. Mackness MI, Durrington PN. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 1995;115(2):243-253.
22. Robbesyn F, Augé N, Vindis C, et al. High-density lipoproteins prevent the oxidized low-density lipoprotein-induced epidermal growth factor receptor activation and subsequent matrix metalloproteinase-2 upregulation. Arterioscler Thromb Vasc Biol. 2005;25(6):1206-1212.
23. 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood. 1985;66(5):1086-1091.
24. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet. 1999;353(9161):1348-1353.
25. Kamboh MI, Ferrell RE. Apolipoprotein H polymorphism and its role in lipid metabolism. Adv Lipid Res. 1991;1(1):9-18.
26. Hammel M, Schwarzenbacher R, Gries A, Kostner GM, Laggner P, Prassl R. Mechanism of the interaction of 2-glycoprotein I with negatively charged phospholipid membrane. Biochemistry. 2001;40(47):14173-14181.
27. Gu W, Ray K, Pearce-Kelling S, et al. Evaluation of APOH gene as a positional candidate for prcd in dogs. Invest Ophthalmol Vis Sci. 1999;40(6):1229-1237.
28. Ouchi M, West K, Crabb JW, Kinoshita S, Kamei M. Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res. 2005;81(2):176-182.
29. Crook M, Chng SI, Lumb P, Reid F. Serum apolipoprotein H and its relationship to blood pressure, serum lipids, fasting plasma glucose and insulin in normal individuals. Ann Clin Biochem. 2001;38(pt 5):494-498.
30. 2-glycoprotein I: localization of the disulfide bridges. Biochemistry. 1992;31(14):3611- 3617.
31. Zhang J, Gerhardinger C, Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes. 2002;51(12):3499-3504.
32. Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 2002;43(4):1104-1108.
33. Niessen HWM, Lagrand WK, Rensink HJAM, Meijer CJLM, Aarden L, Hack CE. Apolipoprotein H, a new mediator in the inflammatory changes ensuing in jeopardised human myocardium. J Clin Pathol. 2000;53(11):863-867.
34. Balasubramanian K, Maiti SN, Schroit AJ. Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis. Apoptosis. 2005;10(2):439-446.
35. 2-Glycoprotein I is a major protein associated with very rapid cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem. 1995;270(43):25845-25849.
36. 2- Glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis. J Cell Biochem. 2005;94(3):485-496.
37. Shanmugaratnam J, Berg E, Kimerer L, et al. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Brain Res Mol Brain Res. 1997;50(1-2):113-120.
38. Li CM, Presley JB, Zhang X, et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J Lipid Res. 2005;46 (4):628-649.
39. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg A. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883-2892.
40. Leung H, Wang JJ, Rochtchina E, Wong TY, Klein R, Mitchell P. Dyslipidaemia and microvascular disease in the retina. Eye. 2005;19(8):861-868.